Health Technology Reassessment: Addressing Uncertainty in Economic Evaluations of Oncology Drugs at Time of Reimbursement Using Long-Term Clinical Trial Data

The evidence base to support reimbursement decision making for oncology drugs is often based on short-term follow-up trial data, and attempts to address this uncertainty are not typically undertaken once a reimbursement decision is made. To address this gap, we sought to conduct a reassessment of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ball, Graeme, Levine, Mitchell A. H., Thabane, Lehana, Tarride, Jean-Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378704/
https://www.ncbi.nlm.nih.gov/pubmed/37504344
http://dx.doi.org/10.3390/curroncol30070484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378704/
https://www.ncbi.nlm.nih.gov/pubmed/37504344
http://dx.doi.org/10.3390/curroncol30070484

Ejemplares similares